A healthcare proposal circulated by the White House in recent days is running into the reality of Republican divisions on the ...
In a proof-of-concept, placebo-controlled trial, the investigational oral selective AKT inhibitor engasertib appeared to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback